Website profile

Mip

Managing IP is the only B2B site uncovering in-house intellectual property strategy and distilling it into actionable intelligence for lawyers globally.

  • 373articles · 365d
  • 2+ day agolatest article
  • Sep 26, 2025earliest in window
  • 92%with images
  • 160avg words
articles per day
Categories
  • Economy, Business & Finance 261
  • Crime & Law 228
  • Law & Government 208
  • Finance & Business 136
  • Business & Industrial 98
  • Crime, Law & Justice 55
  • News 40
  • Science & Technology 29

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

MIP
managingip.com > article > 2gsixxff9bqzehii7t2bk > patents > patent-prosecution-is-a-poker-game-how-examiner-analytics-shape-strategy

‘Patent prosecution is a poker game’: how examiner analytics shape strategy

3+ week, 1+ day ago   (87+ words) Managing Intellectual Property Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND Copyright © Legal Benchmarking Limited and its affiliated companies 2026 ‘Patent prosecution is a poker game’: how examiner analytics shape strategy Examiner statistics could help patent prosecution practitioners…...

MIP
managingip.com > article > 2go73xioppg0kiekbp4w0 > patents > practitioners-eye-trade-secrets-opportunity-as-tech-competition-drives-litigation

Practitioners eye trade secrets opportunity as tech competition drives litigation

1+ mon, 2+ week ago   (93+ words) Managing Intellectual Property Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND Copyright © Legal Benchmarking Limited and its affiliated companies 2026 Practitioners eye trade secrets opportunity as tech competition drives litigation Apple’s lawsuit against OpenAI, which features Tier 1-ranked…...

MIP
managingip.com > article > 2gmgejd8mmuygs1cuy8zk > patents > beyond-the-headlines-the-promise-and-peril-of-the-ip-one-stop-shop

Beyond the headlines: The promise and peril of the IP one-stop shop

1+ mon, 4+ week ago   (100+ words) Managing Intellectual Property Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND Copyright © Legal Benchmarking Limited and its affiliated companies 2026 Beyond the headlines: The promise and peril of the IP one-stop shop As firms expand into integrated IP…...

MIP
managingip.com > article > 2gkxou5h3r5gt83nioxz4 > patents > one-tap-closes-another-opens-uspto-tightens-reexam-procedures

‘One tap closes, another opens’: USPTO tightens reexam procedures

2+ mon, 6+ day ago   (81+ words) Managing Intellectual Property Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND Copyright © Legal Benchmarking Limited and its affiliated companies 2026 ‘One tap closes, another opens’: USPTO tightens reexam procedures IP practitioners debate whether new guidelines will make it…...

MIP
managingip.com > article > 2gfijw4v5x07egwyzy03k > patents > dont-be-influenced-by-trends-frances-ip-office-head-on-the-importance-of-rationality

‘Don’t be influenced by trends’: France’s IP office head on the importance of rationality

3+ mon, 1+ week ago   (431+ words) Welcome to the latest instalment of Managing IP’s ‘Five minutes with’ series, where we learn more about IP practitioners and professionals on a personal and professional level. This time, we meet Pascal Faure, director general of France’s IP office, the…...

MIP
managingip.com > article > 2gegtqs4mahic3l5detxc > patents > build-a-bigger-picture-ip-head-hits-three-decades-at-demarest

‘Build a bigger picture’: IP head hits three decades at Demarest

3+ mon, 3+ week ago   (93+ words) Managing Intellectual Property Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND Copyright © Legal Benchmarking Limited and its affiliated companies 2026 ‘Build a bigger picture’: IP head hits three decades at Demarest Tatiana Campello reflects on 30 years of practising…...

MIP
managingip.com > article > 2gbyzh49pofki71ztakn4 > patents > international-networks-foundational-to-ip-service-despite-what-data-says

International networks ‘foundational’ to IP service, despite what data says

4+ mon, 6+ day ago   (75+ words) Managing Intellectual Property Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND International networks ‘foundational’ to IP service, despite what data says In-house counsel aren’t impressed with law firms’ international networks, but practitioners say they are crucial for…...

MIP
managingip.com > article > 2gbj40y1wkimlhi7cga9s > trademarks > sunday-at-inta-future-proofing-ip-practice-developing-future-leadership

Sunday at INTA: ‘Future-proofing’ IP practice | developing future leadership

4+ mon, 1+ week ago   (1433+ words) In-house and private practice lawyers weighed in on how IP practices can ‘future-proof’ themselves in a tech-driven IP world during a panel session at the INTA Annual Meeting on Sunday, May 3. Michael Woods, senior IP paralegal at Celsius Holdings in…...

MIP
managingip.com > article > 2gaqtzqp8xk8v0et8ak1s > sponsored-content > cnipa-guidance-on-interpreting-swiss-type-claims

CNIPA guidance on interpreting Swiss-type claims

4+ mon, 2+ week ago   (316+ words) In China, medical use of a substance is generally perceived as a method for diagnosing or treating diseases, which is unpatentable under the Patent Law. However, such inventions would be allowed when the claims are reformulated as use of a…...

MIP
managingip.com > article > 2gamfk94yytnecnvs8k5c > sponsored-content > analysis-new-bolar-exemptions-and-imminent-patent-infringement-in-europe

Analysis: New Bolar exemptions and imminent patent infringement in Europe

4+ mon, 2+ week ago   (464+ words) The European Pharma Package, expected to be adopted this summer by the European Parliament and the Council, significantly broadens the Bolar exemption beyond its current scope. This will enable a generic or biosimilar launch on day one after patent or…...